NCT02946034View on ClinicalTrials.gov

Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C

PHASE4CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

September 16, 2020

Study Completion Date

September 16, 2020

Conditions

Chronic Kidney DiseaseChronic Hepatitis C

Interventions

DRUG

Viekira Pak ± ribavirin

12 weeks treatment with AbbVie Viekira Pak ± ribavirin

DRUG

Mavyret

8 or 12 weeks treatment with AbbVie Mavyret

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

Massachusetts General Hospital

OTHER